NO991533L - NMDA (N-metyl-D-aspartat) antagonister - Google Patents

NMDA (N-metyl-D-aspartat) antagonister

Info

Publication number: NO991533L
Authority: NO; Norway
Prior art keywords: nmda; aspartate; antagonists; methyl
Prior art date: 1996-09-30

Application number

NO991533A

Other languages

English (en)

Other versions

NO991533D0 (no

NO314080B1 (no

Inventor

Boyd L Harrison

Raymond S Gross

Bruce M Baron

Original Assignee

Hoechst Marion Roussel Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-09-30

Filing date

1999-03-29

Publication date

1999-05-28

1999-03-29 Application filed by Hoechst Marion Roussel Inc filed Critical Hoechst Marion Roussel Inc

1999-03-29 Publication of NO991533D0 publication Critical patent/NO991533D0/no

1999-05-28 Publication of NO991533L publication Critical patent/NO991533L/no

2003-01-27 Publication of NO314080B1 publication Critical patent/NO314080B1/no

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Vascular Medicine (AREA)
Urology & Nephrology (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Hospice & Palliative Care (AREA)
Psychiatry (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Indole Compounds (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

NO19991533A 1996-09-30 1999-03-29 NMDA (N-metyl-D-aspartat) antagonister, farmasöytisk preparat inneholdendedisse og anvendelse derav for fremstilling av et medikament NO314080B1 (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US72317596A	1996-09-30	1996-09-30
PCT/US1997/014486 WO1998014427A1 (en)	1996-09-30	1997-08-18	Nmda (n-methyl-d-aspartate) antagonists

Publications (3)

Publication Number	Publication Date
NO991533D0 NO991533D0 (no)	1999-03-29
NO991533L true NO991533L (no)	1999-05-28
NO314080B1 NO314080B1 (no)	2003-01-27

Family

ID=24905175

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO19991533A NO314080B1 (no)	1996-09-30	1999-03-29	NMDA (N-metyl-D-aspartat) antagonister, farmasöytisk preparat inneholdendedisse og anvendelse derav for fremstilling av et medikament

Country Status (18)

Country	Link
EP (1)	EP0929521B1 (no)
JP (1)	JP2001501221A (no)
KR (1)	KR20000048715A (no)
CN (1)	CN1139572C (no)
AR (1)	AR009374A1 (no)
AT (1)	ATE309215T1 (no)
AU (1)	AU732997B2 (no)
BR (1)	BR9712144A (no)
CA (1)	CA2266556C (no)
DE (1)	DE69734594T2 (no)
DK (1)	DK0929521T3 (no)
HU (1)	HUP0000882A3 (no)
IL (1)	IL129187A0 (no)
NO (1)	NO314080B1 (no)
NZ (1)	NZ334343A (no)
TW (1)	TW492958B (no)
WO (1)	WO1998014427A1 (no)
ZA (1)	ZA978602B (no)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20010053849A1 (en) *	1999-06-16	2001-12-20	Mary Jeanne Kreek	Plural biological sample arrays, and preparation and uses thereof
CA2407683C (en)	2000-04-28	2010-04-13	Memorial Sloan-Kettering Cancer Center	Topical anesthetic/opioid formulations and uses thereof
HU227197B1 (en)	2000-10-24	2010-10-28	Richter Gedeon Nyrt	Nmda receptor antagonist carboxylic acid amide derivatives and pharmaceutical compositions containing them
US7820688B2 (en)	2001-04-27	2010-10-26	Memorial Sloan-Kettering Cancer Center	Topical anesthetic/opioid formulations and uses thereof
US20030162825A1 (en) *	2001-11-09	2003-08-28	Sepracor Inc.	D-amino acid oxidase inhibitors for learning and memory
DE10306202A1 (de)	2003-02-13	2004-08-26	Grünenthal GmbH	Arzneimittel enthaltend substituierte 2-Aryl-Aminoessigsäure-Verbindungen und/oder substituierte 2-Heteroaryl-Aminoessigsäure-Verbindungen
US7884124B2 (en)	2006-06-30	2011-02-08	Sepracor Inc.	Fluoro-substituted inhibitors of D-amino acid oxidase
RU2453536C2 (ru) *	2007-10-22	2012-06-20	Оркид Рисерч Лабораториз Лимитед	Ингибиторы гистондезацетилазы
CA2788656A1 (en)	2010-02-16	2011-08-25	Pfizer Inc.	(r)-4-((4-((4-(tetrahydrofuran-3-yloxy)benzo[d]isoxazol-3-yloxy)methyl)piperidin-1-yl)methyl)tetrahydro-2h-pyran-4-ol, a partial agonist of 5-ht4 receptors
US11613547B2 (en)	2019-07-08	2023-03-28	University Of Health Sciences & Pharmacy In St. Louis	G-protein biased opioid receptor agonist/analgesics with reduced arrestin recruitment

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ES2088011T3 (es) *	1990-07-16	1996-08-01	Merrell Pharma Inc	Antagonistas de aminoacidos excitadores.
GB9208492D0 (en) *	1992-04-16	1992-06-03	Glaxo Spa	Heterocyclic compounds
CN1051302C (zh) *	1993-05-27	2000-04-12	默里尔药物公司	3－(吲哚－3－基)丙烯酸衍生物及其用作nmda拮抗剂
US5519048A (en) *	1993-05-27	1996-05-21	Merrell Pharmaceuticals Inc.	3-(indol-3-yl)-propenoic acid derivatives and pharmaceutical compositions thereof
GB9319243D0 (en) *	1993-09-17	1993-11-03	Glaxo Spa	Heterocyclic compounds

1997
- 1997-08-18 KR KR1019990702680A patent/KR20000048715A/ko not_active Ceased
- 1997-08-18 CN CNB97198400XA patent/CN1139572C/zh not_active Expired - Fee Related
- 1997-08-18 AT AT97938377T patent/ATE309215T1/de not_active IP Right Cessation
- 1997-08-18 DK DK97938377T patent/DK0929521T3/da active
- 1997-08-18 JP JP10516523A patent/JP2001501221A/ja not_active Ceased
- 1997-08-18 CA CA002266556A patent/CA2266556C/en not_active Expired - Fee Related
- 1997-08-18 IL IL12918797A patent/IL129187A0/xx not_active IP Right Cessation
- 1997-08-18 EP EP97938377A patent/EP0929521B1/en not_active Expired - Lifetime
- 1997-08-18 NZ NZ334343A patent/NZ334343A/xx unknown
- 1997-08-18 BR BR9712144-4A patent/BR9712144A/pt not_active IP Right Cessation
- 1997-08-18 WO PCT/US1997/014486 patent/WO1998014427A1/en not_active Ceased
- 1997-08-18 HU HU0000882A patent/HUP0000882A3/hu unknown
- 1997-08-18 AU AU40718/97A patent/AU732997B2/en not_active Ceased
- 1997-08-18 DE DE69734594T patent/DE69734594T2/de not_active Expired - Fee Related
- 1997-09-24 TW TW086113932A patent/TW492958B/zh not_active IP Right Cessation
- 1997-09-25 ZA ZA9708602A patent/ZA978602B/xx unknown
- 1997-09-29 AR ARP970104462A patent/AR009374A1/es unknown
1999
- 1999-03-29 NO NO19991533A patent/NO314080B1/no unknown

Also Published As

Publication number	Publication date
WO1998014427A1 (en)	1998-04-09
CN1139572C (zh)	2004-02-25
ATE309215T1 (de)	2005-11-15
HUP0000882A2 (hu)	2000-09-28
NO991533D0 (no)	1999-03-29
ZA978602B (en)	1998-03-30
CA2266556C (en)	2007-11-06
CN1232452A (zh)	1999-10-20
AU4071897A (en)	1998-04-24
AR009374A1 (es)	2000-04-12
AU732997B2 (en)	2001-05-03
EP0929521A1 (en)	1999-07-21
HUP0000882A3 (en)	2001-04-28
IL129187A0 (en)	2000-02-17
KR20000048715A (ko)	2000-07-25
DK0929521T3 (da)	2006-03-27
DE69734594D1 (en)	2005-12-15
TW492958B (en)	2002-07-01
BR9712144A (pt)	1999-08-31
DE69734594T2 (de)	2006-07-06
NZ334343A (en)	2001-01-26
NO314080B1 (no)	2003-01-27
EP0929521B1 (en)	2005-11-09
CA2266556A1 (en)	1998-04-09
JP2001501221A (ja)	2001-01-30

Publication	Publication Date	Title
DK1009732T3 (da)	2003-09-22	1-Amino-alkylcyclohexan NMDA receptor antagonister
DK0802910T3 (da)	2002-05-21	Estrogenagonister/antagonister
EE9600186A (et)	1997-08-15	Neurokiniini (tahhüülkiniini) antagonistid
DE69830854D1 (de)	2005-08-18	Mehrfaches testverfahren
NL1008254A1 (nl)	1998-08-18	Testinrichtingen.
EP0986385A4 (en)	2001-05-16	GONADORELIN ANTAGONISTS
DE69622751D1 (de)	2002-09-05	Arbeitsplatz
FI971026A7 (fi)	1997-03-12	Kinoksaliinidioni-NMDA-reseptoriantagonisteja
DE69726660D1 (de)	2004-01-22	Projektionsvorrichtung
FI960516A7 (fi)	1996-08-07	Substituoituja bifenyylisulfonamidiendoteliiniantagonisteja
DK0854867T3 (da)	2002-12-02	Tetrahydroquinoliner som NMDA-antagonister
ATE309215T1 (de)	2005-11-15	Nmda (n-methyl-d-aspartate) antagonists
FI920880A7 (fi)	1992-08-29	NMDA-antagonisteja
FI933762L (fi)	1993-08-26	Nmda antagonister
ATE116653T1 (de)	1995-01-15	Nmda-antagonisten.
KR970702876A (ko)	1997-06-10	뉴로키닌 길항제(Neurokinine (tachykinine) antagonists)
HK1018954A (en)	2000-01-14	Nmda (n-methyl-d-aspartate) antagonists
KR970002813U (ko)	1997-01-24	각도가 있는 컴퓨터용 마우스 판
SE9700316D0 (sv)	1997-02-03	Strömmätare
KR960006324U (ko)	1996-02-17	프로빙 시간단축 쏘소자
KR970047433U (ko)	1997-07-31	어댑터
FI974114A0 (fi)	1997-11-03	Skorstenshatt (regntak)